Zentalis Pharmaceuticals ZNTL

$ 3.0 2.39%

Quarterly report 2024-Q3
added 11-12-2024

Zentalis Pharmaceuticals Income Statement 2011-2024 | ZNTL

Annual Income Statement Zentalis Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	973 M	994 M	3.59 B	1.46 B	-	-	-	-	-	-	-	-	-
Shares	65.4 M	52.9 M	42.7 M	28.1 M	-	-	-	-	-	-	-	-	-
Historical Prices	14.9	18.8	84.1	51.9	-	-	-	-	-	-	-	-	-
Net Income	-292 M	-237 M	-159 M	-118 M	-45.7 M	-21.1 M	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	14 K	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-300 M	-227 M	-217 M	-119 M	-46.8 M	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-298 M	-226 M	-216 M	-119 M	-46.7 M	-23.7 M	-	-	-	-	-	-	-
Operating Expenses	300 M	227 M	217 M	119 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	64.4 M	54.6 M	40.9 M	33.9 M	8.46 M	4.88 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Zentalis Pharmaceuticals

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	71.1 M	71 M	70.9 M	70.8 M	70.6 M	60.8 M	59.3 M	59.3 M	56.8 M	51.1 M	45.2 M	45.5 M	44.6 M	40.7 M	40.4 M	39.9 M	38 M	34.4 M	5.6 M	-	5.6 M	5.6 M	5.59 M	-	-	-	-	5.19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-40.2 M	-88.3 M	10.1 M	-	-55.5 M	-113 M	-63.2 M	-	-54.4 M	-68.4 M	-59.1 M	-50.1 M	-4.19 M	-54.6 M	-49.9 M	-40.3 M	-34.6 M	-26.9 M	-16.1 M	-14.5 M	-12.3 M	-10.5 M	-8.34 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	40.6 M	-	-	-	-	-	-	-	-	-1.83 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-51.4 M	-65.1 M	-24.8 M	-	-62.7 M	-104 M	-65 M	-	-54.2 M	-63.5 M	-57.9 M	-48.2 M	-62.9 M	-55.1 M	-50.3 M	-40.2 M	-34.8 M	-27.4 M	-16.4 M	-14.9 M	-12.6 M	-10.6 M	-8.72 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-51.1 M	-64.8 M	-24.4 M	-	-62.4 M	-104 M	-64.6 M	-	-53.8 M	-63.1 M	-57.5 M	-48.2 M	-62.7 M	-55 M	-50.3 M	-40.2 M	-34.7 M	-27.3 M	-16.4 M	-14.9 M	-12.6 M	-10.6 M	-8.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	51.4 M	65.1 M	65.3 M	-	62.7 M	104 M	65 M	-	54.2 M	63.5 M	57.9 M	48.2 M	62.9 M	55.1 M	50.3 M	40.2 M	34.8 M	27.4 M	16.4 M	14.9 M	12.6 M	10.6 M	8.72 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	14.6 M	16.8 M	15.7 M	-	16 M	15.7 M	16.4 M	-	12 M	19.6 M	11.8 M	9.75 M	8.87 M	10.4 M	12 M	10.7 M	10.1 M	9.92 M	3.14 M	3.04 M	1.84 M	1.95 M	1.63 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency